| Stephanie Lauren Hendricks, PHARMD | |
|
200 Hawkins Dr, Iowa City, IA 52242-1009 | |
| (319) 356-2577 | |
| Not Available |
| Full Name | Stephanie Lauren Hendricks |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 200 Hawkins Dr, Iowa City, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023781911 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 24178 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Lauren Hendricks, PHARMD 200 Hawkins Dr # Cc101gh, Iowa City, IA 52242-1009 Ph: () - | Stephanie Lauren Hendricks, PHARMD 200 Hawkins Dr, Iowa City, IA 52242-1009 Ph: (319) 356-2577 |
News Archive
Virginia Commonwealth University researchers studying hemoglobin genes, mutations of which play a role in genetic blood disorders like sickle cell anemia and beta-thalassemia, have identified two proteins that are responsible for regulating overlapping groups of genes during the development of red blood cells.
Evotec AG today announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule modulators against GPCR and Protease targets involved in various CNS and Metabolic diseases.
New WHO data finds that unsafe food kills an estimated 1.2 million people over the age of five in Southeast Asia and Africa each year, including three times more adults than previously thought, Reuters reports. "It is a picture that we have never had before," WHO Food Safety Director Jorgen Schlundt said. "We now have documentation of a significant burden outside the less than five group, that is major new information."
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.
› Verified 9 days ago
Jess Thompson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Highway 6 W, Iowa City, IA 52246 Phone: 319-338-0581 | |
Kendall Kolk, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2577 | |
Dr. Thomas Johnston Criswell, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Pharmaceutical Care, Iowa City, IA 52242 Phone: 319-356-1616 | |
Jodi Langstaff, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2214 Muscatine Ave, Iowa City, IA 52240 Phone: 319-354-2670 | |
Brittany Wright, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Cc 101 Gh, Iowa City, IA 52242 Phone: 319-356-2577 | |
Patrick Kinn, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2577 | |
Dr. Holly Flynn, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-2577 |